Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Ganser

Showing results (11-20 of 490) with videos related to

Pageof 49
Sort By:
The New England Journal of Medicine|May 21, 2005
Treatment of myelodysplastic syndromesMichael Stadler, Arnold Ganser
Current Opinion in Hematology|December 9, 2016
Therapy-related myeloid neoplasmsArnold Ganser, Michael Heuser
Seminars in Hematology|July 17, 2007
Risks and benefits of erythropoiesis-stimulating agents in cancer managementGernot Beutel, Arnold Ganser
Annals of Hematology|August 4, 2005
Recombinant human erythropoietin in the treatment of nonrenal anemiaMichael Heuser, Arnold Ganser
Expert Review of Hematology|September 9, 2024
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinationsRabia Shahswar, Arnold Ganser
Current Treatment Options in Oncology|July 1, 2020
Treatment of Relapsed Acute Myeloid LeukemiaFelicitas Thol, Arnold Ganser
The Lancet. Haematology|September 3, 2017
Predicting death in patients with acute graft-versus-host disease after reduced-intensity conditioningEva M Weissinger, Arnold Ganser
Current Opinion in Oncology|October 9, 2008
Erythropoietin in cancer-related anemiaMartin H Fenner, Arnold Ganser
Hematology (Amsterdam, Netherlands)|June 16, 2001
The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; MalignancyJÜrgen Krauter, Gerhard Heil, Arnold Ganser
Blood|November 9, 2023
How I treat refractory and relapsed acute myeloid leukemiaFelicitas Thol, Hartmut Döhner, Arnold Ganser
Pageof 49

Showing results (11-20 of 490) with videos related to

Sort By:
Pageof 49
The New England Journal of Medicine|May 21, 2005
Treatment of myelodysplastic syndromesMichael Stadler, Arnold Ganser
Current Opinion in Hematology|December 9, 2016
Therapy-related myeloid neoplasmsArnold Ganser, Michael Heuser
Seminars in Hematology|July 17, 2007
Risks and benefits of erythropoiesis-stimulating agents in cancer managementGernot Beutel, Arnold Ganser
Annals of Hematology|August 4, 2005
Recombinant human erythropoietin in the treatment of nonrenal anemiaMichael Heuser, Arnold Ganser
Expert Review of Hematology|September 9, 2024
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinationsRabia Shahswar, Arnold Ganser
Current Treatment Options in Oncology|July 1, 2020
Treatment of Relapsed Acute Myeloid LeukemiaFelicitas Thol, Arnold Ganser
The Lancet. Haematology|September 3, 2017
Predicting death in patients with acute graft-versus-host disease after reduced-intensity conditioningEva M Weissinger, Arnold Ganser
Current Opinion in Oncology|October 9, 2008
Erythropoietin in cancer-related anemiaMartin H Fenner, Arnold Ganser
Hematology (Amsterdam, Netherlands)|June 16, 2001
The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; MalignancyJÜrgen Krauter, Gerhard Heil, Arnold Ganser
Blood|November 9, 2023
How I treat refractory and relapsed acute myeloid leukemiaFelicitas Thol, Hartmut Döhner, Arnold Ganser
Pageof 49